SER
Serina Therapeutics
$2.10
+$0.03 (+1.45%)Jul 27, 2026
Key metrics
The numbers that frame SER today
- Market cap
- $31.49M
- P/E (TTM)
- -1.5
- EV / FCF
- -0.6
- Gross margin
- 100%
- EV / Sales
- 78.0
- ROIC
- -13,025%
- Div yield
- 0%
- Debt / equity
- 0.2
- 52wk Low
- $1.22
- 52wk High
- $7.91
Growth
Revenue and earnings trend for SER
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about SER
Is Serina Therapeutics a good buy?
No. Serina Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks mixed. The support signal is useful, but not decisive. We think Serina Therapeutics is selling at a very high price.
What is the market capitalization of SER?
Serina Therapeutics's market capitalization is $31.49M.
What is the P/E ratio for SER stock?
Serina Therapeutics's current P/E ratio is -1.5.
What is the 52-week high for SER stock?
The 52-week high for Serina Therapeutics is $7.91. The current close of $2.10 is 73.5% below that high.
What is the 52-week low for SER stock?
The 52-week low for Serina Therapeutics is $1.22. The current close of $2.10 is 72.1% above that low.
Does SER stock pay dividends?
Serina Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for SER?
Serina Therapeutics's Debt / Equity ratio is 0.18.